Condition: Zhejiang University · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
The goal of this study is o evaluate the prognostic effect of fexofenadine hydrochloride in patients with myocardial infarction
This description comes directly from the study's public registry record.
Cheng Ni · +8615088555539 · cescni@zju.edu.cn
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Zhejiang University, School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07381803